comparemela.com

Latest Breaking News On - Agendia mammaprint - Page 1 : comparemela.com

National Advertising Division Recommends Agendia Modify or Discontinue Certain Claims for MammaPrint and BluePrint Breast Cancer Tests

German Gynecological Oncology Group (AGO) Recognizes BluePrint® in Breast Cancer Guidelines

German Gynecological Oncology Group (AGO) Recognizes BluePrint® in Breast Cancer Guidelines
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Agendia And Agilent Announce Plans To Jointly Develop New Diagnostic Tests, Extend Supply Agreement

AMSTERDAM, Netherlands and SANTA CLARA, California, April 22 /PRNewswire/ Agendia BV, a world leader in the rapidly evolving field of molecular diagnostics, and Agilent Technologies, Inc. (NYSE: A), today announced terms under which they intend to collaborate to develop new in-vitro diagnostic tests.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.